Shenzhen Chipscreen Biosciences Co (688321) — Strategic Asset Allocation Index
Shenzhen Chipscreen Biosciences Co (688321) has a Strategic Asset Allocation Index of 61.1% as of June 2023. Strategic assets (PP&E of CN¥1.09 Billion plus long-term investments of CN¥-) total CN¥1.09 Billion, measured against net assets of CN¥1.78 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 688321 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Shenzhen Chipscreen Biosciences Co Strategic Asset Allocation Index (2016–2021)
This chart shows how Shenzhen Chipscreen Biosciences Co's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of June 2023, the index stands at 61.1%, representing strategic assets of CN¥1.09 Billion against net assets of CN¥1.78 Billion CNY. See 688321 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Shenzhen Chipscreen Biosciences Co (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen Chipscreen Biosciences Co from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Shenzhen Chipscreen Biosciences Co stock valuation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 49.3% | CN¥698.99 Million | CN¥698.99 Million | CN¥- | CN¥1.42 Billion | ▲ +10.1 pp |
| 2020 | 39.2% | CN¥586.28 Million | CN¥586.28 Million | CN¥- | CN¥1.49 Billion | ▲ +13.0 pp |
| 2019 | 26.3% | CN¥379.99 Million | CN¥379.99 Million | CN¥- | CN¥1.45 Billion | ▼ -32.7 pp |
| 2018 | 59.0% | CN¥281.47 Million | CN¥281.47 Million | CN¥- | CN¥476.90 Million | ▲ +18.4 pp |
| 2017 | 40.6% | CN¥183.14 Million | CN¥183.14 Million | CN¥- | CN¥450.55 Million | ▲ +18.5 pp |
| 2016 | 22.1% | CN¥47.17 Million | CN¥47.17 Million | CN¥- | CN¥213.40 Million | — |